Skip to main content
. 2021 Feb 1;12(1):116–131. doi: 10.14336/AD.2020.0320

Figure 7.

Figure 7.

LRIC treatment regulated circulating pro-inflammatory and anti-inflammatory factors. (A) pro-inflammatory cytokines CXCL1, TNFα, IL-1β, IFNγ,IL-5, and IL-6 levels in plasma. (B) anti-inflammatory cytokines IL-10, IL-13, and IL-4 levels in plasma. Data are expressed as mean ± SD, * P<0.05, * * P<0.01, * * * P<0.001, WKY-CON vs. SHR-CON, SHR-CON vs. SHR-RIC. N = 5 each group.